Aquatherapy for Parkinson's (NCT07390825)

Improve walking balance via aquatherapy

Trial ID
NCT07390825
Official Title
Evaluation of the Effects of Aquatic Therapy on Activities of Daily Living, Walking, Balance, Posture, Pain, and Depression in Parkinson's Patients
Goal
Improve walking balance via aquatherapy
Phase
NA
Status
RECRUITING
Sponsor
Ankara City Hospital Bilkent
Study Type
INTERVENTIONAL
Enrollment
42 participants
Conditions
Parkinson Disease
Interventions
Aquatherapy, home exercise

Summary For Families

The goal is to see whether regular aquatic therapy can improve daily activities, walking, balance, posture, pain, and depression in people with mild to moderate Parkinson's. Participants get supervised aquatic therapy in warm water, where buoyancy reduces joint load and fall risk, gentle water resistance helps strengthen muscles and practice gait and balance, and the soothing environment can ease pain and lift mood; this is a physical therapy approach that complements, and does not interact with, usual medications like levodopa. The trial is looking for adults 40 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3, on a stable medication plan for at least 3 months, cognitively able (MMSE 24+), and able to stand and walk with or without assistance.

Locations

  • Bilkent City Hospital, Çankaya, Ankara, Turkey (Türkiye)
  • Bilkent City Hospital, Ankara, ÇANKAYA, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying Aquatherapy. The goal is to see whether regular aquatic therapy can improve daily activities, walking, balance, posture, pain, and depression in people with mild to moderate Parkinson's. Participants get supervised aquatic therapy in warm water, where buoyancy reduces joint load and fall risk, gentle water resistance helps strengthen muscles and practice gait and balance, and the soothing environment can ease pain and lift mood; this is a physical therapy approach that complements, and does not interact with, usual medications like levodopa. The trial is looking for adults 40 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3, on a stable medication plan for at least 3 months, cognitively able (MMSE 24+), and able to stand and walk with or without assistance.
Who can participate?
Participants must be between 40 Years and 80 Years.
Where is this trial located?
This trial is recruiting at 2 locations.
Does it cost anything to join?
You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
How long does the trial last?
This trial is estimated to last approximately 1 year and 7 months.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
Will I get a placebo in this trial?
There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
How many visits does this trial involve?
Patients will be evaluated before and after treatment.
What procedures are involved in this trial?
Based on the protocol, this trial involves: Walking & movement tests (non-invasive); Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.

Related Reading

View on ClinicalTrials.gov